| 53 |
May 3, 2002 |
Hemispherx continues to attempt to renew its over 13-year-old fraudulent AIDS promotion.
|
| 52 |
February 22, 2002 |
Hemispherx’s questionable defamation case under jury deliberation.
|
| 51 |
February 22, 2002 |
Jury finds Asensio did not defame Hemispherx.
|
| 50 |
February 2, 2002 |
New letter to Congress on significance of Hemispherx’s corporate irresponsibility.
|
| 49 |
January 28, 2002 |
AMEX failure leads to congressional investigation.
|
| 48 |
January 28, 2002 |
NASD’s AMEX censured, floor chief barred and Chairman resigns as a result of the GAO’s investigation of its harassment of Asensio & Company, Inc.
|
| 47 |
December 18, 2001 |
HEB uses anti-terrorism scam in latest AMEX pump and dump operation, reports Asensio & Company.
|
| 46 |
December 18, 2001 |
Hemispherx grossly misrepresents AHRQ report.
|
| 45 |
December 18, 2001 |
Even Carter’s co-conspirator objects to smallpox claims.
|
| 44 |
December 18, 2001 |
AMEX failed to close down Hemispherx’s warrant fraud.
|
| 43 |
November 21, 2001 |
Even Carter’s co-conspirator objects to latest scam.
|
| 42 |
October 2, 2001 |
AMEX’s Hemispherx stock fraud exceeds 30 million shares.
|
| 41 |
September 25, 2001 |
Ampligen and its clinical trials found flawed and useless, reports Asensio & Company, Inc.
|
| 40 |
February 8, 2001 |
Hemispherx issues yet another false and fraudulent release.
|
| 39 |
July 26, 2000 |
FDA charges Hemispherx with false and misleading Ampligen promote.
|
| 38 |
July 25, 2000 |
Hemispherx cited in three criminal indictments.
|
| 37 |
June 8, 2000 |
Asensio wins against Hemispherx.
|
| 36 |
June 1, 2000 |
KPMG terminates its five-year audit relationship with Hemispherx.
|
| 35 |
April 19, 2000 |
Hemispherx’s forced to make damning admissions.
|
| 34 |
March 17, 2000 |
Hemispherx charged with deception by AIDS organization. UCI denies having received Hemispherx’s alleged research grants.
|
| 33 |
August 10, 1999 |
Letter to FDA regarding Hemispherx cost recovery.
|
| 32 |
August 10, 1999 |
Hemispherx continues attempts to control its stock trading.
|
| 31 |
July 29, 1999 |
Yet another fraudulent stock promoter tied to Hemispherx.
|
| 30 |
July 14, 1999 |
Hemispherx fabricates false quotes from CFIDS Network.
|
| 29 |
July 13, 1999 |
Hemispherx’s Dr. Carter tied to “advocacy group” promotion of Ampligen despite FDA violation notice and restriction.
|
| 28 |
May 21, 1999 |
Hemispherx officers tied to other manipulated stocks.
|
| 27 |
May 13, 1999 |
AMEX fails to commence enforcement action against Hemispherx.
|
| 26 |
May 13, 1999 |
Compilation of Hemispherx’s false and fraudulent investor representations.
|
| 25 |
May 11, 1999 |
Hemispherx analyst makes false Ampligen HIV efficacy claims despite failed test and FDA violation notice.
|
| 24 |
March 18, 1999 |
Hemispherx Suffers Major Loss in Federal Court.
|
| 23 |
December 8, 1998 |
Leading researchers find CFS to be psychosomatic.
|
| 22 |
November 18, 1998 |
Hemispherx report reveals insider “pump and dump” operation.
|
| 21 |
October 28, 1998 |
Hemispherx issues false and exaggerated CFS prevalence rates.
|
| 20 |
October 28, 1998 |
Hemispherx’s CFS prevalence disclosures proven false.
|
| 19 |
October 28, 1998 |
Hemispherx confirms failure to disclose FDA violation.
|
| 18 |
October 27, 1998 |
FDA determines Hemispherx’s Ampligen claims violate regulations.
|
| 17 |
October 27, 1998 |
Hemispherx issues blatantly false FDA infraction statement.
|
| 16 |
October 14, 1998 |
Hemispherx’s hubris expands to legal profession.
|
| 15 |
October 14, 1998 |
Hemispherx CFS Phase III and orphan approvals found to be six years old.
|
| 14 |
October 13, 1998 |
Ampligen Safety Profile.
|
| 13 |
October 12, 1998 |
Hemispherx’s CFS conference presentations widely ignored.
|
| 12 |
October 8, 1998 |
Hemispherx distributes fraudulent Oprah Winfrey videotape.
|
| 11 |
October 1, 1998 |
Dr. Carter’s DuPont and Stratton-Oakmont assertions show intent to defraud.
|
| 10 |
October 1, 1998 |
Asensio & Company denies all charges in Hemispherx’s press release.
|
| 9 |
October 1, 1998 |
Hemispherx exposed to FDA sanctions.
|
| 8 |
September 30, 1998 |
Hemispherx attempts to prevent stock sale.
|
| 7 |
September 30, 1998 |
Hemispherx attempts to use false CFS prevalence rate in attempt to defraud investors.
|
| 6 |
September 30, 1998 |
Letter to FDA concerning Hemispherx violation of FDA regulations.
|
| 5 |
September 30, 1998 |
Hemispherx continues fraudulent stock promotion.
|
| 4 |
September 24, 1998 |
Hemispherx Announces Deal with Convicted Former-NCI Researcher.
|
| 3 |
September 22, 1998 |
Hemispherx’s Ampligen has no medical or economic value.
|
| 2 |
September 22, 1998 |
Asensio & Company, Inc. releases research report on Hemispherx Biopharma.
|
| 1 |
September 22, 1998 |
STRONG SELL RECOMMENDATION
|
